Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 6
1946 8
1947 13
1948 4
1949 2
1950 2
1951 5
1952 2
1953 3
1954 13
1955 10
1956 7
1957 3
1958 4
1959 1
1960 11
1961 4
1970 4
1971 3
1972 1
1973 1
1974 2
1976 2
1977 1
1978 4
1979 2
1980 1
1981 3
1982 1
1983 1
1986 6
1987 3
1988 1
1989 3
1990 7
1991 3
1992 3
1993 5
1994 6
1995 6
1996 3
1997 10
1998 7
1999 14
2000 12
2001 9
2002 13
2003 6
2004 18
2005 21
2006 21
2007 28
2008 25
2009 31
2010 26
2011 20
2012 24
2013 28
2014 49
2015 50
2016 50
2017 47
2018 49
2019 53
2020 55
2021 68
2022 48
2023 45
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

883 results

Results by year

Filters applied: . Clear all
Page 1
[Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Alsuliman T, Aubrun C, Bay JO, Beguin Y, Bigenwald C, Brissot E, Chalandon Y, Chevallier P, Pagliuca S, Magro L, Srour M. Alsuliman T, et al. Among authors: chevallier p. Bull Cancer. 2024 Apr 16:S0007-4551(24)00119-X. doi: 10.1016/j.bulcan.2024.02.013. Online ahead of print. Bull Cancer. 2024. PMID: 38631984 French.
Late Relapse after Allogeneic Stem Cell Transplantation in Patients Treated for Acute Myeloid Leukemia: Relapse Incidence, Characteristics, Role of Conditioning Regimen, and Outcome.
Antier C, Jullien M, Tessoulin B, Loirat M, Peterlin P, Garnier A, Le Bourgeois A, Chevallier P, Guillaume T. Antier C, et al. Among authors: chevallier p. Cancers (Basel). 2024 Apr 5;16(7):1419. doi: 10.3390/cancers16071419. Cancers (Basel). 2024. PMID: 38611097 Free PMC article.
Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation in an adult: A case report.
Peterlin P, Bonnelye J, Garnier A, Le Bourgeois A, Guillaume T, Jullien M, Dutartre H, Le Moigne M, Schmitt C, Gouya L, Poli A, Barbarot S, Chevallier P. Peterlin P, et al. Among authors: chevallier p. Skin Health Dis. 2024 Jan 27;4(2):e342. doi: 10.1002/ski2.342. eCollection 2024 Apr. Skin Health Dis. 2024. PMID: 38577034 Free PMC article.
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Villar S, Chevret S, Poire X, Joris M, Chevallier P, Bourhis JH, Forcade E, Chantepie S, Beauvais D, Raus N, Bay JO, Loschi M, Devillier R, Duléry R, Ceballos P, Rubio MT, Servais S, Nguyen S, Robin M. Villar S, et al. Among authors: chevallier p. Bone Marrow Transplant. 2024 Mar 21. doi: 10.1038/s41409-024-02268-5. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38514813
Correction to: French Interventional Radiology Centers' Uptake of Transradial Approach and Outpatient Hepatocellular Carcinoma Intra-arterial Treatments.
Grégory J, Ronot M, Laurent V, Chabrot P, de Baere T, Chevallier P, Vilgrain V, Aubé C; French Society of Abdominal and Gastrointestinal Imaging (SIAD) and French Society of Interventional and Cardiovascular Imaging (SFICV). Grégory J, et al. Among authors: chevallier p. Cardiovasc Intervent Radiol. 2024 Apr;47(4):531. doi: 10.1007/s00270-024-03698-w. Cardiovasc Intervent Radiol. 2024. PMID: 38491166 No abstract available.
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Chalandon Y, Rousselot P, Chevret S, Cayuela JM, Kim R, Huguet F, Chevallier P, Graux C, Thiebaut-Bertrand A, Chantepie SP, Thomas X, Vincent L, Berthon C, Hicheri Y, Raffoux E, Escoffre-Barbe M, Plantier I, Joris M, Turlure P, Pasquier F, Belhabri A, Roth Guepin G, Blum S, Gregor M, Lafage-Pochitaloff M, Quessada J, Lheritier V, Clappier E, Boissel N, Dombret H. Chalandon Y, et al. Among authors: chevallier p. Blood. 2024 Mar 7:blood.2023023502. doi: 10.1182/blood.2023023502. Online ahead of print. Blood. 2024. PMID: 38452207
On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
Leroyer EH, Petitpain N, Morisset S, Neven B, Castelle M, Winter S, Souchet L, Morel V, Le Cann M, Fahd M, Yacouben K, Mechinaud F, Ouachée-Chardin M, Renard C, Wallet HL, Angoso M, Jubert C, Chevallier P, Léger A, Rialland F, Dhedin N, Robin C, Maury S, Beckerich F, Beauvais D, Cluzeau T, Loschi M, Fernster A, Bittencourt MC, Cravat M, Bilger K, Clément L, Decot V, Gauthier M, Legendre A, Larghero J, Ouedrani A, Martin-Blondel G, Pochon C, Reppel L, Rouard H, Nguyen-Quoc S, Dalle JH, D'Aveni M, Bensoussan D. Leroyer EH, et al. Among authors: chevallier p. Hemasphere. 2024 Jan 27;8(1):e40. doi: 10.1002/hem3.40. eCollection 2024 Jan. Hemasphere. 2024. PMID: 38434523 Free PMC article. No abstract available.
Haploidentical stem cell donor choice for patients with acute myeloid leukemia: A study from the ALWP of the EBMT.
Sanz J, Labopin M, Blaise D, Raiola AM, Busca A, Vydra J, Tischer J, Chevallier P, Bramanti S, Fanin R, Socié G, Forcade E, Kröger N, Koc Y, Itälä-Remes M, Zecca M, Nagler A, Brissot E, Spyridonidis A, Bazarbachi A, Giebel S, Piemontese S, Mohty M, Ciceri F. Sanz J, et al. Among authors: chevallier p. Blood Adv. 2024 Mar 1:bloodadvances.2023012133. doi: 10.1182/bloodadvances.2023012133. Online ahead of print. Blood Adv. 2024. PMID: 38429091
883 results